ATR is a high-affinity specific inhibitor of ANT; the depletion or chemical inhibition of ANT2 improves the liver steatosis by reducing hepatic TG level (Cho et al., 2017), implying the potential effect of ATR on NAFLD treatment. The gene discussed is ATR; the disease is fatty liver disease.